Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans.

Finan B, Ma T, Ottaway N, Müller TD, Habegger KM, Heppner KM, Kirchner H, Holland J, Hembree J, Raver C, Lockie SH, Smiley DL, Gelfanov V, Yang B, Hofmann S, Bruemmer D, Drucker DJ, Pfluger PT, Perez-Tilve D, Gidda J, Vignati L, Zhang L, Hauptman JB, Lau M, Brecheisen M, Uhles S, Riboulet W, Hainaut E, Sebokova E, Conde-Knape K, Konkar A, DiMarchi RD, Tschöp MH.

Sci Transl Med. 2013 Oct 30;5(209):209ra151. doi: 10.1126/scitranslmed.3007218.

2.

Long-term systemic exposure of orlistat, a lipase inhibitor, and its metabolites in obese patients.

Zhi J, Mulligan TE, Hauptman JB.

J Clin Pharmacol. 1999 Jan;39(1):41-6.

PMID:
9987699
3.

Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers.

Zhi J, Melia AT, Guerciolini R, Chung J, Kinberg J, Hauptman JB, Patel IH.

Clin Pharmacol Ther. 1994 Jul;56(1):82-5.

PMID:
8033498
4.

Initial studies in humans with the novel gastrointestinal lipase inhibitor Ro 18-0647 (tetrahydrolipstatin).

Hauptman JB, Jeunet FS, Hartmann D.

Am J Clin Nutr. 1992 Jan;55(1 Suppl):309S-313S. doi: 10.1093/ajcn/55.1.309s. Review.

PMID:
1728845
5.

Serum triglyceride responses.

Demise JJ, Hauptman JB, Dunton AW.

Am J Clin Nutr. 1989 Feb;49(2):389-91. No abstract available.

PMID:
2916455
6.

Pheochromocytoma resistant to alpha-adrenergic blockade.

Hauptman JB, Modlinger RS, Ertel NH.

Arch Intern Med. 1983 Dec;143(12):2321-3.

PMID:
6139989
7.

Adrenergic blockade in pheochromocytoma.

Modlinger RS, Ertel NH, Hauptman JB.

Arch Intern Med. 1983 Dec;143(12):2245-6. No abstract available.

PMID:
6139986

Supplemental Content

Loading ...
Support Center